Novo Nordisk Sheds 3% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price Novo Nordisk Sheds 3% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price · Investor's Business Daily ALLISON GATLIN Fri, May 16, 2025, 9:00 AM 5 min read In This Article: VKTX LLY AMGN NONOF NVO Novo Nordisk said Friday it will replace its CEO, citing a sharp tumble for Novo shares amid growing competition. Continue Reading View Comments Terms and Privacy Policy Your Privacy Choices Utah Privacy Notice More Info Recommended Stories